Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Research Article Volume 4 Issue 12

Depression Accelerates Tumor Cell Proliferation Via Regulating Serotonin/miR-144 Axis in NSCLC Mice

Guangquan Xu1, Yongchao Li1, Ruidong Zhu1, Pengcheng Song1, Youlei Wei1, Tian Liang2 and Tianze Zhang1*

1Department of Thoracic Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China
2Department of Obstetrics and Gynaecology, The 1st Affiliated Hospital of Harbin Medical University, China

*Corresponding Author: Tianze Zhang, Department of Thoracic Surgery, the 2nd Affiliated Hospital of Harbin Medical University, China.

Received: September 24, 2020; Published: November 28, 2020

Reprints View PDF Related Articles

×

Abstract

  Non-small cell lung cancer is known as a malignant tumor with low survival rate and poor prognosis. Depression affects various diseases. However, the effect of depression on the progression of NSCLC remains unclear. In our current study, chronic mild stress (CMS) mice was used as depression animal model. Depression prompted the tumor progression in vivo analysis, including increasing tumor indexes and reducing survival rate. Serotonin secretion was observed to be remarkable elevation in both serum and tumor tissue, which was positively related with tumor progression. In vitro assays, serotonin promoted the proliferation of A549 cells. Additionally, we observed that miR-144 expression was significantly downregulated in serotonin stimulated group. Further loss-of- and gain-of-function assays verified that miR-144 was the downstream factor of serotonin underlying the condition of CMS. Taken together, our research indicated that CMS-induced serotonin secretion accelerates NSCLC proliferation via inhibiting miR-144 expression, suggesting the potential therapeutic direction in NSCLC patients.

Keywords: Depression; Chronic Mild Stress; miR-144; NSCLC

×

References

  1. Herbst RS., et al. “The biology and management of non-small cell lung cancer”. Nature 7689 (2018): 446-454.
  2. Relli V., et al. “Abandoning the Notion of Non-Small Cell Lung Cancer”. Trends in Molecular Medicine7 (2019): 585-594.
  3. Zhao C., et al. “IL‑17 induces NSCLC A549 cell proliferation via the upregulation of HMGA1, resulting in an increased cyclin D1 expression”. International Journal of Oncology5 (2018): 1579-1592.
  4. Meng L., et al. “Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress”. Thoracic Cancer 4 (2019): 676-685.
  5. McFarland DC., et al. “Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients”. Psychoncology 9 (2019): 1461-1469.
  6. Jacobs JM., et al. “Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study”. Journal of Psychosomatic Research 99 (2017): 28-33.
  7. Antoniuk S., et al. “Chronic unpredictable mild stress for modeling depression in rodents: Meta-analysis of model reliability”. Neuroscience and Biobehavioral Reviews 99 (2019): 101-116.
  8. Ross RA., et al. “The Role of Chronic Stress in Anxious Depression”. Chronic Stress (Thousand Oaks) 1 (2017): 2470547016689472.
  9. Headrick JP., et al. “The heartbreak of depression: 'Psycho-cardiac' coupling in myocardial infarction”. Journal of Molecular and Cellular Cardiology 106 (2017): 14-28.
  10. Berk M., et al. “So depression is an inflammatory disease, but where does the inflammation come from?” BMC Medicine 11 (2013): 200.
  11. Nagaich AK and Misra K. “Highly efficient synthesis of oligodeoxyribonucleotides using alpha-phenyl cinnamoyl group for selective amino protection”. Nucleic Acids Research13 (1989): 5125-5134.
  12. Sotelo JL., et al. “The biology of depression in cancer and the relationship between depression and cancer progression”. International Review of Psychiatry1 (2014): 16-30.
  13. Cvetković J and Nenadović M. “Depression in breast cancer patients”. Psychiatry Research 240 (2016): 343-347.
  14. Yeung KS., et al. “Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance”. Psychiatry Research5 (2018): 865-891.
  15. Barreto FS., et al. “Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer”. Behavioural Pharmacology 29 (2018): 165-180.
  16. Selim AM., et al. “Plasma Serotonin in Heart Failure: Possible Marker and Potential Treatment Target”. Heart, Lung and Circulation5 (2017): 442-449.
  17. Aloisi G., et al. “Depression and heart failure: an intricate relationship”. Monaldi Archives for Chest Disease 3 (2019).
  18. Mota CMD., et al. “Central serotonin attenuates LPS-induced systemic inflammation”. Brain, Behavior, and Immunity 66 (2017): 372-381.
  19. Shajib MS., et al. “Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation”. ACS Chemical Neuroscience 5 (2017): 920-931.
  20. Siddiqui EJ., et al. “The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation”. BJU International3 (2006): 634-639.
  21. Siddiqui EJ., et al. “The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation”. Journal of Urology 176 (2006): 1648-1653.
  22. Zhang T., et al. “Transcription Factor p53 Suppresses Tumor Growth by Prompting Pyroptosis in Non-Small-Cell Lung Cancer”. Oxidative Medicine and Cellular Longevity (2019): 8746895.
  23. Lv H., et al. “Chronic mild stress induced anxiety-like behaviors can Be attenuated by inhibition of NOX2-derived oxidative stress”. Journal of Psychiatric Research 114 (2019): 55-66.
  24. Park CH., et al. “Protective Effects of Serotonin and its Derivatives, N-Feruloylserotonin and N- (p-Coumaroyl) Serotonin, Against Cisplatin-Induced Renal Damage in Mice”. American Journal of Chinese Medicine2 (2019): 369-383.
  25. Mitazaki S., et al. “Apocynin reduced doxycycline-induced acute liver injury in ovariectomized mice”. Toxicology Reports 3 (2016): 357-363.
  26. Song L., et al. “Hippocampal PPARα is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice”. British Journal of Pharmacology14 (2018): 2968-2987.
  27. Cerulo G., et al. “Serotonin activates cell survival and apoptotic death responses in cultured epithelial thyroid cells”. Biochimie 105 (2014): 211-5.
  28. Mundalil Vasu M., et al. “Fluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell Lines”. PLoS One10 (2016): e0164425.
  29. Chen YJ., et al. “Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data”. Respiratory Research1 (2019): 48.
  30. Song L., et al. “miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2”. Biomed Research International (2018): 5109497.
  31. Wang X., et al. “Circulating microRNA-144-5p is associated with depressive disorders”. Clinical Epigenetics 1 (2015): 69.
  32. Ma K., et al. “The molecular mechanism underlying GABAergic dysfunction in nucleus accumbens of depression-like behaviours in mice”. Journal of Cellular and Molecular Medicine10 (2019): 7021-7028.
  33. Short AK., et al. “Elevated paternal glucocorticoid exposure alters the small noncoding RNA profile in sperm and modifies anxiety and depressive phenotypes in the offspring”. Translational Psychiatry6 (2016): e837.
  34. Stewart DJ. “Wnt signaling pathway in non-small cell lung cancer”. Journal of the National Cancer Institute 1 (2014): djt356.
  35. Zou J., et al. “Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway”. Biomed Pharmacotherapy 108 (2018): 130-136.
  36. Li X., et al. “Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer”. Cellular Physiology and Biochemistry5 (2018): 2324-2340.
  37. Wang X., et al. “Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137”. Genetic Testing and Molecular Biomarkers 6 (2018): 333-342.
  38. Yang YN., et al. “MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4”. Pathology - Research and Practice10 (2019): 152555.
  39. Li S., et al. “The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis”. Journal of Cellular Physiology9 (2018): 6679-6688.
  40. Li X., et al. “The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients”. International Journal of Oncology2 (2015): 798-808.
  41. Romanelli J., et al. “The significance of depression in older patients after myocardial infarction”. Journal of the American Geriatrics Society5 (2002): 817-22.
  42. Williams SA., et al. “Depression and risk of heart failure among the elderly: a prospective community-based study”. Psychosomatic Medicine1 (2002): 6-12.
  43. Pirl WF., et al. “Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol 30.12 (2012): 1310-1315.
  44. Sarrouilhe D., et al. “Serotonin and cancer: what is the link?” Current Molecular Medicine1 (2015): 62-77.
  45. Kraus C., et al. “Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression”. Neuroscience and Biobehavioral Reviews 77 (2017): 317-326.
  46. Abdul M., et al. “Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists”. Anticancer Research 14 (1994): 1215-1220.
  47. Dizeyi N., et al. “Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines”. Urologic Oncology4 (2011): 436-445.
  48. Li H., et al. “MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals”. Artificial Cells, Nanomedicine, and Biotechnology 1 (2019): 3163-3171.
  49. Zhang Y., et al. “Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo”. Journal of Cellular Physiology10 (2019): 18679-18687.
  50. Zhou X., et al. “TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis”. Oncotarget41 (2016): 67196-67211.
  51. He Z., et al. “The involvement of miR-150/β-catenin axis in colorectal cancer progression”. Biomedicine and Pharmacotherapy 121 (2020): 109495.
  52. Wu J., et al. “MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer”. Journal of Physiology and Biochemistry2 (2019): 143-152.
  53. Tian QG., et al. “The role of miR-144/GSPT1 axis in gastric cancer”. European Review for Medical and Pharmacological Sciences13 (2018): 4138-4145.
  54. Choi HH., et al. “Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening”. Oncology3 (2019): 173-179.
  55. Lu M., et al. “circRACGAP1 promotes non-small cell lung cancer proliferation by regulating miR-144-5p/CDKL1 signaling pathway”. Cancer Gene Therapy (2020).
×

Citation

Citation: Tianze Zhang., et al. “Depression Accelerates Tumor Cell Proliferation Via Regulating Serotonin/miR-144 Axis in NSCLC Mice". Acta Scientific Pharmaceutical Sciences 4.12 (2020): 63-72.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.